Zobrazeno 1 - 4
of 4
pro vyhledávání: '"J Thaddeus Beck"'
Autor:
Patrick Neven, Xavier Pivot, Antonia Ridolfi, Brad Lanoue, J. Thaddeus Beck, Guy Jerusalem, Arnd Nusch, Francisco J. Esteva, Giulia Bianchi, David Chandiwana, Miguel Martin, Karen Rodriguez Lorenc, Peter A. Fasching, Arlene Chan, Yingbo Wang, Michele De Laurentiis
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 54, Iss, Pp 148-154 (2020)
Breast, Vol 54, Iss, Pp 148-154 (2020)
Purpose In the MONALEESA-3 Phase III trial of patients with hormone receptor–positive human epidermal growth factor receptor–negative advanced breast cancer, ribociclib plus fulvestrant significantly improved progression-free survival (PFS) and o
Autor:
Antonio Cubillo Gracian, Marina Nechaeva, Ramesh K. Ramanathan, Danielle Sullivan, Jordan Berlin, Elena Elez Fernandez, Ralf Hofheinz, Vera Gorbunova, Dustin A. Deming, Alison Torres, J. Thaddeus Beck, Yan Luo, László Mangel, P. García-Alfonso
Publikováno v:
British Journal of Cancer
Background Metastatic colorectal cancer (mCRC) has low survival rates. We assessed if addition of veliparib, concurrent to FOLFIRI, improves survival in patients with previously untreated mCRC. Methods This study compared veliparib (200 mg BID for 7
Autor:
Seock-Ah Im, Francisco J. Esteva, Debu Tripathy, Denise A. Yardley, Joohyuk Sohn, Karen Rodriguez Lorenc, Juan Pablo Zarate, J. Thaddeus Beck, Howard A. Burris, Stephen Chia, Arlene Chan, Antonia Ridolfi, Patrick Neven, Lowell L. Hart, Aditya Bardia
Publikováno v:
Br J Cancer
Background This pooled analysis of MONALEESA trials evaluated the safety of ribociclib plus endocrine therapy (RIB + ET) with a focus on dose reductions in first-line patients. Methods In the dose reduction analysis, data were pooled from MONALEESA-2
Publikováno v:
Cancer treatment reviews. 69
Metastatic breast cancer (MBC) is the leading cause of cancer-related morbidity and mortality among women worldwide. Endocrine therapy is the standard of care for the most common subtype of MBC, hormone-receptor positive (HR+), human epidermal growth